About 200mg Votrient Pazopanib Tablets
Capitalise on our new release: 200mg Votrient Pazopanib Tablets-an inestimable addition to targeted cancer therapy. Each laureate box contains 30 film-coated, oval tablets formulated with the active salt Pazopanib, offering unprecedented efficacy for anti-cancer treatment. Designed for oral administration, these light yellow tablets are prescribed for patients requiring a modern approach to cancer management. Store below 30C in a dry location to preserve their efficacy. Discover the benefit of this targeted therapy, sourced from a respected exporter, supplier, and trader in India.
Extensive Application and Specialized Features
200mg Votrient Pazopanib Tablets are primarily used in advanced cancer treatment centres and oncology clinics, prescribed for patients requiring intervention in certain types of cancers. As a potent anti-cancer agent, it is uniquely designed for targeted therapy. Distinctive features include its film-coated design, precise 200 mg dosage, and stability under specific storage conditions, making it exceptionally reliable and efficient for medical professionals dedicated to innovative cancer management.
Export Markets and Delivery Advantages
Our premium 200mg Votrient Pazopanib Tablets are delivered to international markets spanning Asia, Africa, and beyond. We offer an assured sample policy, with minimal charges where applicable, so prospective clients can evaluate quality firsthand. Delivery is designed for promptness and reliability, ensuring that the product consistently arrives on time and in optimal condition. As a leading exporter, supplier, and trader from India, customer satisfaction and swift order processing are at the core of our priorities.
FAQ's of 200mg Votrient Pazopanib Tablets:
Q: How should 200mg Votrient Pazopanib Tablets be administered?
A: These tablets are taken orally, usually once daily, as directed by a healthcare provider. They must be swallowed whole with water and should not be crushed or chewed.
Q: What is the main benefit of using Votrient Pazopanib Tablets for cancer treatment?
A: The main benefit lies in its targeted therapy approach, focusing on inhibiting cancer cell growth with minimal impact on healthy cells, thus improving treatment outcomes and patient tolerance.
Q: When is it recommended to start treatment with these tablets?
A: Initiation of treatment should be determined by an oncologist based on the specific cancer type, its stage, and the patient's medical history. It often applies to advanced or metastatic cases.
Q: Where should Votrient Pazopanib Tablets be stored for optimum efficacy?
A: Tablets should be stored below 30C in a dry place, away from direct sunlight and moisture, to maintain their potency and safety throughout the shelf life.
Q: What is the process for obtaining a sample of the product?
A: Interested parties may request samples, typically subject to a nominal charge as per our sample policy. Please contact our sales team for the exact process and terms.
Send Inquiry
